Registry of Patient With M. Dupuytren and Validation of the Brief MHQ
NCT ID: NCT01876498
Last Updated: 2016-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2013-08-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment
NCT01715467
Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease
NCT03000114
Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture
NCT01226121
Health-Related Quality of Life in Patients With Dupuytren's Disease
NCT00468949
Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence
NCT06142929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with M. Dupuytren
Xiaflex Surgery
Xiaflex surgery
Xiaflex surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xiaflex surgery
Xiaflex surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Schulthess Klinik
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Herren
Dr. med. Daniel Herren
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Herren, Dr. med.
Role: STUDY_CHAIR
Schulthess Klinik
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schulthess Klinik
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dupuytren 1
Identifier Type: REGISTRY
Identifier Source: secondary_id
Brief MHQ1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.